ESR1 and cancer: In addition, it is noted that data from bi-dimensional ER+ cancer cells [10, 59-63, 67-70], including results from the present study, support the conclusion that estradiol also potently promotes glycolytic and OxPhos activation in 3D-rearregment cancer cell models.